Docetaxel: standard recommended dose of 100 mg/m(2) is effective but not feasible for some metastatic breast cancer patients heavily pretreated with chemotherapy-A phase II single-center study (Q73181364)
Jump to navigation
Jump to search
scientific article published on 01 April 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Docetaxel: standard recommended dose of 100 mg/m(2) is effective but not feasible for some metastatic breast cancer patients heavily pretreated with chemotherapy-A phase II single-center study |
scientific article published on 01 April 1999 |
Statements
Docetaxel: standard recommended dose of 100 mg/m(2) is effective but not feasible for some metastatic breast cancer patients heavily pretreated with chemotherapy-A phase II single-center study (English)
E Salminen
M Bergman
S Huhtala